Philippine Hypertension Guidelines
The Philippines has its own national clinical practice guideline for hypertension management, published in 2020 by the Philippine Society of Hypertension in collaboration with multiple medical societies. 1
Overview of the 2020 Philippine CPG
The 2020 Philippine Clinical Practice Guidelines for Hypertension were developed specifically to address the local context and rising burden of hypertension in the Philippines, where prevalence increased from 22% in the 1990s to 37% by 2021, with poor blood pressure control being a major concern 1, 2.
Key Features of the Philippine Guidelines
The guideline was developed using the ADAPTE process and addresses 30 clinical questions commonly encountered in Filipino practice, organized into six clusters 1. The development involved:
- Multiple Philippine medical societies working collaboratively
- A technical working group analyzing evidence specific to Filipino populations
- Panel of local experts for discussion and approval
- Focus on evidence-based care tailored to Philippine healthcare settings
Scope of Recommendations
The 2020 Philippine CPG provides comprehensive guidance on:
- Definition of hypertension: Office BP ≥140/90 mmHg following proper standard BP measurement 2
- Treatment thresholds and blood pressure targets
- Appropriate medications to reach targets
- Management of uncomplicated hypertension
- Special populations including:
- Patients with diabetes
- Stroke survivors
- Chronic kidney disease
- Pregnant women
- Pediatric populations
- Screening and monitoring protocols
- Identification of high cardiovascular risk groups
Additional Philippine Guidelines
A 2024 update specifically addresses acute severe blood pressure elevation, developed by the Philippine Society of Hypertension and Philippine Heart Association 3. This guideline:
- Provides 11 recommendations and 4 best practice statements
- Uses the GRADE approach through Evidence to Decision framework
- Targets general practitioners, specialists, emergency personnel, and healthcare workers
- Addresses both inpatient and outpatient settings
Context: The Philippine Hypertension Burden
The guidelines were developed in response to concerning local data 2:
- Only 52% of hypertensive Filipinos are aware of their diagnosis
- Treatment rate: 68%
- Adherence rate: 86%
- BP control rate: only 27% (later improved to 37%)
- Over 80% receive monotherapy, which likely contributes to poor control rates
- Common complications: stroke (11.6%), ischemic heart disease (7.7%), chronic kidney disease (6.3%)
Complementary Screening Guidelines
The Philippine CPG for Periodic Health Examination (2021) provides strong recommendations FOR screening for hypertension as part of routine health examinations 4, reinforcing the importance of early detection in the Filipino population.
Accessing the Guidelines
These guidelines are intended for Filipino healthcare professionals to provide evidence-based care and help reduce cardiovascular risk in the local population. The recommendations are specifically adapted to address the unique challenges of hypertension management in the Philippine healthcare system, including medication access, economic considerations, and local practice patterns 1, 2.